Research by Royal College of Surgeons in Ireland (RCSI) University of Medicine and Health Sciences has discovered a new role for the blood clotting protein known as von Willebrand Factor (VWF), which could lead to the development of new treatments for patients with inflammatory and blood clotting disorders.